Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation
Clinical trial NCT05593328 · COMPLETED
Trial details
- NCT number
- NCT05593328
- Sponsor
- Cardiff Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-17
- Primary completion
- 2024-12-09
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.